Actually, several studies reported an increased level of IL-6 also in other different clinical settings such as sedentary behavior, obesity, diabetes, cardiovascular diseases, cancer, and recently in COVID-19 patients with poor outcomes, all characterized by a high mortality rate. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.